




Searching News Database: Genzyme
HSMN NewsFeed - 23 Oct 2024
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
HSMN NewsFeed - 25 Jul 2022
HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer
HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer
HSMN NewsFeed - 6 Jul 2022
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
HSMN NewsFeed - 29 Jun 2022
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
HSMN NewsFeed - 26 Oct 2021
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
HSMN NewsFeed - 24 Aug 2020
Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans
Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans
HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Acquist Therapeutics Announces New Appointments to its Board of Directors
HSMN NewsFeed - 26 May 2020
Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
HSMN NewsFeed - 10 Jun 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
HSMN NewsFeed - 1 Aug 2018
Oncorus(R), Inc., Names Industry Veteran Ted Ashburn as new President and CEO
Oncorus(R), Inc., Names Industry Veteran Ted Ashburn as new President and CEO
HSMN NewsFeed - 13 Dec 2017
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
HSMN NewsFeed - 3 Oct 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
HSMN NewsFeed - 6 Sep 2017
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
HSMN NewsFeed - 30 Aug 2017
PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President
PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President
HSMN NewsFeed - 14 Aug 2017
Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
HSMN NewsFeed - 15 Jun 2017
Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
HSMN NewsFeed - 19 May 2017
Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
HSMN NewsFeed - 7 Apr 2017
Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer
Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer
HSMN NewsFeed - 8 Mar 2017
AzurRx Announces Addition of Charles J Casamento to the Board of Directors
AzurRx Announces Addition of Charles J Casamento to the Board of Directors
HSMN NewsFeed - 9 Feb 2017
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
HSMN NewsFeed - 21 Jul 2016
ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer
ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer
HSMN NewsFeed - 20 Jul 2016
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
HSMN NewsFeed - 9 Jun 2016
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
HSMN NewsFeed - 15 Mar 2016
CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors
CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors
HSMN NewsFeed - 3 Nov 2015
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
HSMN NewsFeed - 21 Oct 2015
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
HSMN NewsFeed - 1 Oct 2015
BioMarin to Acquire Rights to Phenylketonuria (PKU) Franchise From Merck Serono
BioMarin to Acquire Rights to Phenylketonuria (PKU) Franchise From Merck Serono
HSMN NewsFeed - 18 Sep 2015
Momenta Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Momenta Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
HSMN NewsFeed - 13 Aug 2015
Check-Cap Announces Appointment of William Densel as Chief Executive Officer and Director
Check-Cap Announces Appointment of William Densel as Chief Executive Officer and Director
HSMN NewsFeed - 11 Aug 2015
Ovid Therapeutics Completes Oversubscribed $75 Million Series B Financing
Ovid Therapeutics Completes Oversubscribed $75 Million Series B Financing
HSMN NewsFeed - 22 Jul 2015
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
HSMN NewsFeed - 16 Jul 2015
Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors
Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors
HSMN NewsFeed - 15 Jul 2015
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
HSMN NewsFeed - 16 Jun 2015
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
HSMN NewsFeed - 8 Jun 2015
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
HSMN NewsFeed - 27 May 2015
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
HSMN NewsFeed - 12 Dec 2014
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
HSMN NewsFeed - 30 Jul 2014
Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer
Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer
HSMN NewsFeed - 21 Mar 2014
Genzyme’s Lemtrada(TM) Approved in Brazil for Treatment of Multiple Sclerosis
Genzyme’s Lemtrada(TM) Approved in Brazil for Treatment of Multiple Sclerosis
HSMN NewsFeed - 13 Mar 2014
Anika Therapeutics Announces Dismissal of MONOVISC(R) U.S. Patent Infringement Lawsuit
Anika Therapeutics Announces Dismissal of MONOVISC(R) U.S. Patent Infringement Lawsuit
HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
HSMN NewsFeed - 21 Jan 2014
Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
HSMN NewsFeed - 30 Dec 2013
Genzyme Receives Complete Response Letter from FDA on Lemtrada(TM) (alemtuzumab) Application
Genzyme Receives Complete Response Letter from FDA on Lemtrada(TM) (alemtuzumab) Application
HSMN NewsFeed - 19 Dec 2013
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
HSMN NewsFeed - 19 Dec 2013
Genzyme’s Lemtrada(TM) Approved in Australia for Treatment of Multiple Sclerosis
Genzyme’s Lemtrada(TM) Approved in Australia for Treatment of Multiple Sclerosis
HSMN NewsFeed - 13 Dec 2013
Genzyme’s Lemtrada(TM) Approved in Canada for Treatment of Multiple Sclerosis
Genzyme’s Lemtrada(TM) Approved in Canada for Treatment of Multiple Sclerosis
HSMN NewsFeed - 12 Dec 2013
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
HSMN NewsFeed - 16 Oct 2013
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
HSMN NewsFeed - 15 Oct 2013
La Jolla Pharmaceutical Company Announces Appointment of Two Additional Independent Directors
La Jolla Pharmaceutical Company Announces Appointment of Two Additional Independent Directors
HSMN NewsFeed - 8 Oct 2013
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
HSMN NewsFeed - 3 Oct 2013
Aubagio(R) Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study
Aubagio(R) Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study
HSMN NewsFeed - 17 Sep 2013
European Commission Approves Genzyme’s Multiple Sclerosis Treatment Lemtrada(TM) (alemtuzumab)
European Commission Approves Genzyme’s Multiple Sclerosis Treatment Lemtrada(TM) (alemtuzumab)
HSMN NewsFeed - 3 Sep 2013
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
HSMN NewsFeed - 28 Aug 2013
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
HSMN NewsFeed - 10 Jul 2013
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
HSMN NewsFeed - 28 Jun 2013
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
HSMN NewsFeed - 12 Apr 2013
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
HSMN NewsFeed - 19 Mar 2013
bioTheranostics Adds Chief Medical Officer & Vice President of Medical, Clinical & Regulatory Affairs
bioTheranostics Adds Chief Medical Officer & Vice President of Medical, Clinical & Regulatory Affairs
HSMN NewsFeed - 4 Mar 2013
Intercept Pharmaceuticals Appoints Daniel Regan as Chief Commercial Officer
Intercept Pharmaceuticals Appoints Daniel Regan as Chief Commercial Officer
HSMN NewsFeed - 26 Feb 2013
Bausch & Lomb Names Robert Bertolini President And Chief Financial Officer
Bausch & Lomb Names Robert Bertolini President And Chief Financial Officer
HSMN NewsFeed - 21 Feb 2013
ARIAD Announces Appointment of European General Manager and Other Key Members of Leadership Team
ARIAD Announces Appointment of European General Manager and Other Key Members of Leadership Team
HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
HSMN NewsFeed - 7 Nov 2012
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
HSMN NewsFeed - 11 Oct 2012
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
HSMN NewsFeed - 3 Oct 2012
Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
HSMN NewsFeed - 18 Sep 2012
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
HSMN NewsFeed - 4 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
HSMN NewsFeed - 25 Jul 2012
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
HSMN NewsFeed - 18 Jul 2012
Lantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International
Lantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International
HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
HSMN NewsFeed - 2 Apr 2012
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
HSMN NewsFeed - 2 Apr 2012
MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives
MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives
HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
HSMN NewsFeed - 29 Feb 2012
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
HSMN NewsFeed - 16 Feb 2012
GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development
GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development
HSMN NewsFeed - 5 Dec 2011
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 14 Nov 2011
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
HSMN NewsFeed - 11 Oct 2011
Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
HSMN NewsFeed - 8 Sep 2011
Catabasis Pharmaceuticals Appoints Joanne M. Donovan, M.D., Ph.D., to Chief Medical Officer
Catabasis Pharmaceuticals Appoints Joanne M. Donovan, M.D., Ph.D., to Chief Medical Officer
HSMN NewsFeed - 1 Aug 2011
Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.
Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.
HSMN NewsFeed - 20 Jul 2011
Agennix Hires Christine Boisclair as Senior Vice President of Global Regulatory Affairs
Agennix Hires Christine Boisclair as Senior Vice President of Global Regulatory Affairs
HSMN NewsFeed - 29 Jun 2011
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
HSMN NewsFeed - 11 Apr 2011
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
HSMN NewsFeed - 16 Feb 2011
sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right
sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right
HSMN NewsFeed - 24 Jan 2011
Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive
Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive
HSMN NewsFeed - 4 Oct 2010
Genzyme Board Urges Shareholders to Take No Action On sanofi-aventis’ Unsolicited Tender Offer
Genzyme Board Urges Shareholders to Take No Action On sanofi-aventis’ Unsolicited Tender Offer
HSMN NewsFeed - 23 Sep 2010
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
HSMN NewsFeed - 10 Aug 2010
Gregory Miller Joins Concert Pharmaceuticals as Head of Business and Corporate Development
Gregory Miller Joins Concert Pharmaceuticals as Head of Business and Corporate Development
HSMN NewsFeed - 20 Jul 2010
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
HSMN NewsFeed - 22 Jun 2010
International Stem Cell Corporation Names Charles J. Casamento to Board of Directors
International Stem Cell Corporation Names Charles J. Casamento to Board of Directors
HSMN NewsFeed - 13 Jan 2010
The Foundry Announces Completion of Series A Financing for Twelfth Company
The Foundry Announces Completion of Series A Financing for Twelfth Company
HSMN NewsFeed - 8 Jan 2010
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
HSMN NewsFeed - 17 Dec 2009
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
HSMN NewsFeed - 7 Oct 2009
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
HSMN NewsFeed - 10 Sep 2009
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
HSMN NewsFeed - 8 Sep 2009
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
HSMN NewsFeed - 1 Jun 2009
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
HSMN NewsFeed - 13 May 2009
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
HSMN NewsFeed - 8 Apr 2009
ORTHOCON Announces Appointment of New CEO and $25 Million Series B Financing
ORTHOCON Announces Appointment of New CEO and $25 Million Series B Financing
HSMN NewsFeed - 19 Mar 2009
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
HSMN NewsFeed - 12 Mar 2009
Dune Medical Devices Appoints William Densel President U.S. and Chief Business Officer
Dune Medical Devices Appoints William Densel President U.S. and Chief Business Officer
HSMN NewsFeed - 2 Mar 2009
BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer
BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
HSMN NewsFeed - 15 Jan 2009
Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program
Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program
HSMN NewsFeed - 15 Jan 2009
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
HSMN NewsFeed - 10 Nov 2008
Targeted Genetics Board of Directors Names B.G. Susan Robinson as President and CEO
Targeted Genetics Board of Directors Names B.G. Susan Robinson as President and CEO
HSMN NewsFeed - 6 Aug 2008
Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
HSMN NewsFeed - 8 May 2008
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
HSMN NewsFeed - 25 Apr 2008
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
HSMN NewsFeed - 19 Mar 2008
Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients
Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients
HSMN NewsFeed - 12 Mar 2008
iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
HSMN NewsFeed - 22 Jan 2008
Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
HSMN NewsFeed - 7 Jan 2008
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
HSMN NewsFeed - 7 Jan 2008
Naviscan PET Systems Announces New Commercial and Technology Leadership Team
Naviscan PET Systems Announces New Commercial and Technology Leadership Team
HSMN NewsFeed - 7 Jan 2008
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
HSMN NewsFeed - 7 Jan 2008
Callisto Pharmaceuticals Amends and Restates Atiprimod License Agreement with Genzyme
Callisto Pharmaceuticals Amends and Restates Atiprimod License Agreement with Genzyme
HSMN NewsFeed - 17 Dec 2007
Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
HSMN NewsFeed - 13 Dec 2007
Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
HSMN NewsFeed - 27 Nov 2007
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
HSMN NewsFeed - 25 Oct 2007
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
HSMN NewsFeed - 9 Oct 2007
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
HSMN NewsFeed - 4 Oct 2007
Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
HSMN NewsFeed - 27 Sep 2007
Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
HSMN NewsFeed - 13 Aug 2007
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
HSMN NewsFeed - 19 Jul 2007
Genzyme Announces Phase 3 Trial of Mozobil in non-Hodgkin's Lymphoma Meets Primary Endpoint
Genzyme Announces Phase 3 Trial of Mozobil in non-Hodgkin's Lymphoma Meets Primary Endpoint
HSMN NewsFeed - 16 Jul 2007
Dr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of Directors
Dr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of Directors
HSMN NewsFeed - 18 Jun 2007
Atherotech Names Leading High Tech Heart Disease Prevention Expert as Chief Medical Officer
Atherotech Names Leading High Tech Heart Disease Prevention Expert as Chief Medical Officer
HSMN NewsFeed - 24 May 2007
BioMarin Submits New Drug Application for U.S. Marketing Authorization of Kuvan for Phenylketonuria (PKU)
BioMarin Submits New Drug Application for U.S. Marketing Authorization of Kuvan for Phenylketonuria (PKU)
HSMN NewsFeed - 16 May 2007
Genzyme Announces Positive Initial Observations in Trial Evaluating Novel Oral Treatment for Gaucher Disease
Genzyme Announces Positive Initial Observations in Trial Evaluating Novel Oral Treatment for Gaucher Disease
HSMN NewsFeed - 11 Apr 2007
Mike Bernstein Appointed Vice President of Regulatory Affairs, DFB Branded Pharmaceuticals
Mike Bernstein Appointed Vice President of Regulatory Affairs, DFB Branded Pharmaceuticals
HSMN NewsFeed - 9 Apr 2007
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
HSMN NewsFeed - 21 Dec 2006
Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis
Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis
HSMN NewsFeed - 18 Dec 2006
BioMarin Announces Positive Results From Phase 3 Extension Study of Phenoptin for PKU
BioMarin Announces Positive Results From Phase 3 Extension Study of Phenoptin for PKU
HSMN NewsFeed - 15 Dec 2006
Lipoxen Announces $75M Agreement With Baxter to Develop New Blood Clotting Factors
Lipoxen Announces $75M Agreement With Baxter to Develop New Blood Clotting Factors
HSMN NewsFeed - 12 Dec 2006
Donald S. Masters, Ph.D. Named New President and CEO of Triton BioSystems, Inc.
Donald S. Masters, Ph.D. Named New President and CEO of Triton BioSystems, Inc.
HSMN NewsFeed - 30 Nov 2006
Sirtris Pharmaceuticals Obtains Exclusive Rights to Key Sirtuin Technology from MIT
Sirtris Pharmaceuticals Obtains Exclusive Rights to Key Sirtuin Technology from MIT
HSMN NewsFeed - 27 Nov 2006
Genzyme Begins Phase 2 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Genzyme Begins Phase 2 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
HSMN NewsFeed - 9 Nov 2006
Study in Today's New England Journal of Medicine Shows Benefits of Thymoglobulin Use
Study in Today's New England Journal of Medicine Shows Benefits of Thymoglobulin Use
HSMN NewsFeed - 8 Nov 2006
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
HSMN NewsFeed - 10 Oct 2006
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
HSMN NewsFeed - 2 Oct 2006
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
HSMN NewsFeed - 26 Sep 2006
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
HSMN NewsFeed - 25 Sep 2006
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
HSMN NewsFeed - 21 Sep 2006
Latest Data Confirm Benefits of Evoltra(R) in Children with Relapsed/Refractory Acute Leukemia
Latest Data Confirm Benefits of Evoltra(R) in Children with Relapsed/Refractory Acute Leukemia
HSMN NewsFeed - 14 Sep 2006
Amicus Therapeutics Raises $60 Million Series D Financing; Company Also Makes Two Key Executive Appointments
Amicus Therapeutics Raises $60 Million Series D Financing; Company Also Makes Two Key Executive Appointments
HSMN NewsFeed - 6 Sep 2006
Genzyme Begins Phase 3 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Genzyme Begins Phase 3 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
HSMN NewsFeed - 26 May 2006
MultiCell Technologies Appoints Stephen Chang, Ph.D. as Chief Executive Officer
MultiCell Technologies Appoints Stephen Chang, Ph.D. as Chief Executive Officer
HSMN NewsFeed - 24 May 2006
Dyax Announces the Appointment of Peggy Berry as Senior Vice President of Quality and Regulatory Affairs
Dyax Announces the Appointment of Peggy Berry as Senior Vice President of Quality and Regulatory Affairs
HSMN NewsFeed - 16 May 2006
Bioenvision and Mayne Pharma Announce Marketing and Distribution Agreement for Evoltra(R)
Bioenvision and Mayne Pharma Announce Marketing and Distribution Agreement for Evoltra(R)
HSMN NewsFeed - 10 May 2006
Proteon Therapeutics Hires Veteran Biotechnology Executive Timothy Noyes as CEO
Proteon Therapeutics Hires Veteran Biotechnology Executive Timothy Noyes as CEO
Additional items found! 241

Members Archive contains
241 additional stories matching:
Genzyme
(Password required)
Genzyme
(Password required)